Episode 54: Long-term follow up on the SCHEDULE trial
Description
On the second December episode of JHLT: The Podcast, the Digital Media Editors explore another paper from the December issue of JHLT, entitled “Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial.”
First author Entela Bollano, MD, PhD, and senior author Niklas Bergh, MD, PhD, both from the Sahlgrenska University Hospital in Sweden, join the podcast to discuss their work.
You’ll hear about:
- Past outcomes of the SCHEDULE trial, including reduced CAV in patients on everolimus over patients on CNIs
- How this study filled the need for long-term follow up on randomized studies on immunosuppression
- Limitations of the study, and what additional follow up might teach us
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you’re an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Lung clinicians: if you haven’t yet tuned in for the first episode from this month, check it out! The paper discusses the effects of pollution post lung transplantation.
Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
United States
